toggle menu

Sourcing & Management of Health Products

The Global Fund / Karin Schermbrucker

HIV & Malaria Rapid Diagnostic Tests

The Global Fund is working with partners and manufacturers of rapid diagnostic tests for HIV and malaria to establish market demand and support procurement of these diagnostics products and related laboratory items for implementing partners.

HIV Global Diagnostic Working Group

The HIV Global Diagnostic Working Group provides a forum to share information and align actions and communications related to improving access to quality-assured, HIV-related in vitro diagnostics for patients.

The Global Fund and the United States Agency for International Development host the working group. Members of the working group include stakeholders of various interests and mandates and include:

  • African Society for Laboratory Medicine
  • Centers for Disease Control and Prevention
  • Clinton Health Access Initiative
  • The Global Fund
  • Médecins Sans Frontières
  • United Nations Children's Fund
  • Unitaid
  • United States Agency for International Development
  • President's Emergency Plan for AIDS Relief
  • World Health Organization: Prequalification of In Vitro Diagnostics Program and HIV Department
The Global Fund is committed to increasing access to quality-assured rapid diagnostic tests. Other public sector buyers should reach out to Azizkhon Jafarov at to learn how to access our negotiated terms and pricing.

Documents related to our strategy are available for download here.

  • Reference Prices and Procurement Planning Documents

The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website.

To consent to the use of cookies, please click “Accept”.

To learn more about your rights and options, please read our Privacy Statement.

Accept